secwatch.observer — SEC 8-K summary
======================================

Issuer:     Seres Therapeutics, Inc. (MCRB)
CIK:        0001609809
Form:       8-K
Filed at:   2024-01-30T23:59:59+00:00
Accession:  0001193125-24-019398
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Seres Therapeutics sets 2024 annual meeting for April 4, 2024
-------------------------------------------------------------

- Record date for voting is February 12, 2024; meeting will be held virtually.
- Stockholder proposals and director nominations must be received by February 9, 2024.
- Deadline for compliance with universal proxy rules under Rule 14a-19 also applies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609809/000119312524019398/0001193125-24-019398-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609809/000119312524019398/d742357d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-019398

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer